Colorectal cancer screening: prospects for molecular stool analysis (original) (raw)

• Parkin, D. M. Global cancer statistics in the year 2000. Lancet Oncol. 2, 533–543 (2001).
  Article CAS PubMed Google Scholar
• Hayne, D. et al. Current trends in colorectal cancer: site, incidence, mortality and survival in England and Wales. Clin. Oncol. (R. Coll. Radiol.) 13, 448–452 (2001).
  CAS Google Scholar
• Mamazza, J. & Gordon, P. H. The changing distribution of large intestinal cancer. Dis. Colon Rectum 25, 558–562 (1982).
  Article CAS PubMed Google Scholar
• McCallion, K. et al. Flexible sigmoidoscopy and the changing distribution of colorectal cancer: implications for screening. Gut 48, 522–525 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Cucino, C., Buchner, A. M. & Sonnenberg, A. Continued rightward shift of colorectal cancer Dis. Colon Rectum 45, 1035–1040 (2002).
  Article PubMed Google Scholar
• Cooper, G. S., Yuan, S., Landefeld, C. S., Johanson, J. F. & Rimm, A. A. A national population-based study of colorectal cancer and age: implications for screening in older Americans. Cancer 75, 775–781 (1995).
  Article CAS PubMed Google Scholar
• Rabeneck, L., Davila, J. A. & El-Serag, H. B. Is there a true 'shift' to the right colon in the incidence of colorectal cancer? Am. J. Gastroenterol. 98, 1400–1409 (2003).
  PubMed Google Scholar
• Morson, B. C. Evolution of cancer of the colon and rectum. Cancer 34 (Suppl.), 845–849 (1974).
  Article Google Scholar
• Fearon, E. R. & Vogelstein, B. A genetic model for colorectal tumorigenesis. Cell 61, 759–767 (1990).
  Article CAS PubMed Google Scholar
• Kinzler, K. W. & Vogelstein B. Lessons from hereditary colorectal cancer. Cell 87, 159–170 (1996).
  Article CAS PubMed Google Scholar
• Kozuka, S., Nogaki, M., Ozeki, T. & Masumori, S. Premalignancy of the mucosal polyp in the large intestine: II. Estimation of the periods required for malignant transformation of mucosal polyps. Dis. Colon Rectum 18, 494–500 (1975).
  Article CAS PubMed Google Scholar
• O'Brien, M. J. et al. The National Polyp Study. Patient and polyp characteristics associated with high-grade dysplasia in colorectal adenomas. Gastroenterology 98, 371–379 (1990).
  Article CAS PubMed Google Scholar
• Kudo, S., Kashida, H. & Tamura, T. Early colorectal cancer: flat or depressed type. J. Gastroenterol. Hepatol. 15 (Suppl.), D66–D70 (2000).
  Article PubMed Google Scholar
• Umetani, N. et al. Involvement of APC and K-ras mutation in non-polypoid colorectal tumorigenesis. Br. J. Cancer 82, 9–15 (2000).
  Article CAS PubMed Google Scholar
• Hirota, S. et al. p53 immunoreactive stain and early colorectal adenocarcinomas. Eur. J. Cancer 31A, 2220–2222 (1995).
  Article CAS PubMed Google Scholar
• Wada, R. et al. Histopathological studies of superficial-type early colorectal carcinoma. Cancer 77, 44–50 (1996).
  Article CAS PubMed Google Scholar
• Chung, D. C. & Rustgi, A. K. DNA mismatch repair and cancer. Gastroenterology 109, 1685–1699 (1995).
  Article CAS PubMed Google Scholar
• Thibodeau, S. N., Bren, G. & Schaid, D. Microsatellite instability in cancer of the proximal colon. Science 260, 816–819 (1993).
  Article CAS PubMed Google Scholar
• Frayling, I. M. Microsatellite instability. Gut 45, 1–4 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Rhodes, J. M. Colorectal cancer screening in the UK: joint position statement by the British Society of Gastroenterology, the Royal College of Physicians, and the Association of Coloproctology of Great Britain and Ireland. Gut 46, 746–748 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Baldwin, P., Laskey, R. & Coleman, N. Translational approaches to improve cervical screening. Nature Rev. Cancer 3, 217–226 (2003).
  Article CAS Google Scholar
• Winawer, S. et al. Gastrointestinal Consortium Panel. Colorectal cancer screening and surveillance: clinical guidelines and rationale—update based on new evidence. Gastroenterology 124, 544–560 (2003).
  Article PubMed Google Scholar
• Newcomb, P. A., Norfleet, R. G., Storer, B. E., Surawicz, T. S. & Marcus, P. M. Screening sigmoidoscopy and colorectal cancer mortality. J. Natl Cancer Inst. 84, 1572–1575 (1992).
  Article CAS PubMed Google Scholar
• Selby, J. V., Friedman, G. D., Quesenberry, C. P. Jr. & Weiss, N. S. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N. Engl. J. Med. 326, 653–657 (1992).
  Article CAS PubMed Google Scholar
• Muller, A. D. & Sonnenberg, A. Prevention of colorectal cancer by flexible sigmoidoscopy and polypectomy. A case-control study of 32,702 veterans. Ann. Intern. Med. 123, 904–910 (1995).
  Article CAS PubMed Google Scholar
• Newcomb, P. A., Storer, B. E., Morimoto, L. M., Templeton, A. & Potter, J. D. Long-term efficacy of sigmoidoscopy in the reduction of colorectal cancer incidence. J. Natl Cancer Inst. 95, 622–625 (2003).
  Article PubMed Google Scholar
• Pickhardt, P. J. et al. Computed tomographic virtual colonoscopy to screen for colorectal neoplasia in asymptomatic adults. N. Engl. J. Med. 349, 2191–2200 (2003).
  Article CAS PubMed Google Scholar
• Luboldt, W. et al. Computer-aided diagnosis in contrast-enhanced CT colonography: an approach based on contrast. Eur. Radiol. 12, 2236–2241 (2002).
  Article PubMed Google Scholar
• Ahlquist, D. A., McGill, D. B., Schwartz., S., Taylor, W. F. & Owen, R. A. Fecal blood levels in health and disease. N. Engl. J. Med. 312, 1422–1428 (1985).
  Article CAS PubMed Google Scholar
• Young, G. P. & St. John, D. J. Selecting an occult blood test for use as a screening tool for large bowel cancer. Front. Gastrointest. Res. 18, 135–156 (1991).
  Article CAS Google Scholar
• Macrae, F. A. & St. John, D. J. Relationship between patterns of bleeding and Haemoccult sensitivity in patients with colorectal cancers or adenomas. Gastroenterology 82, 891–898 (1982).
  CAS PubMed Google Scholar
• Ahlquist, D. A. et al. Patterns of occult bleeding in asymptomatic colorectal cancer. Cancer 63, 1826–1830 (1989).
  Article CAS PubMed Google Scholar
• Mandel, J. S. et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N. Engl. J. Med. 328, 1365–1371 (1993). The first published randomized trial to show a reduction in mortality from CRC following FOBT screening.
  Article CAS PubMed Google Scholar
• Mandel, J. S., Church, T. R., Ederer, F. & Bond, J. H. Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood. J. Natl Cancer Inst. 91, 434–437 (1999).
  Article CAS PubMed Google Scholar
• Kronborg, O., Fenger, C., Olsen J., Jorgensen, O. D. & Sondergaard, O. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 348, 1467–1471 (1996).
  Article CAS PubMed Google Scholar
• Jorgensen, O. D., Kronborg, O. & Fenger, C. A randomised study of screening for colorectal cancer using faecal occult blood testing: results after 13 years and seven biennial screening rounds. Gut 50, 29–32 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Hardcastle, J. D. et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 348, 1472–1477 (1996).
  Article CAS PubMed Google Scholar
• Mandel, J. S. et al. The effect of fecal occult-blood screening on the incidence of colorectal cancer. N. Engl. J. Med. 343, 1603–1607 (2000).
  Article CAS PubMed Google Scholar
• Towler, B. P., Irwig, L., Glasziou, P., Weller, D. & Kewenter, J. Screening for colorectal cancer using the faecal occult blood test, Hemoccult. Cochrane Database Syst. Rev. 2, CD001216 (1998).
  Google Scholar
• Cole, S. R. & Young, G. P. Effect of dietary restriction on participation in faecal occult blood test screening for colorectal cancer. Med. J. Aust. 175, 195–198 (2001).
  CAS PubMed Google Scholar
• Young, G. P. et al. Prescreening evaluation of a brush-based faecal immunochemical test for haemoglobin. J. Med. Screen. 10, 123–128 (2003).
  Article CAS PubMed Google Scholar
• Cole, S. R., Young, G. P., Esterman, A., Cadd, B. & Morcom, J. A randomised trial of the impact of new faecal haemoglobin test technologies on population participation in screening for colorectal cancer. J. Med. Screen. 10, 117–122 (2003).
  Article CAS PubMed Google Scholar
• Nakajima, M. et al. Prevention of advanced colorectal cancer by screening using the immunochemical faecal occult blood test: a case-control study. Br. J. Cancer 89, 23–28 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Gilbert, J. A. et al. Fecal marker variability in colorectal cancer: calprotectin versus hemoglobin. Scand. J. Gastroenterol. 31, 1001–1005 (1996).
  Article CAS PubMed Google Scholar
• Johne, B., Kronberg, O., Ton, H. I., Kristinsson, J. & Fuglerud, P. A new fecal calprotectin test for colorectal neoplasia. Scand. J. Gastroenterol. 3, 291–296 (2001).
  Article Google Scholar
• Limburg, P. J. et al. Prospective evaluation of fecal calprotectin as a screening biomarker for colorectal neoplasia. Am. J. Gastroenterol. 98, 2299–2305 (2003).
  Article CAS PubMed Google Scholar
• Hoff, G. et al. Testing for calprotectin (PhiCal) in the Norwegian Colorectal Cancer Prevention trial on flexible sigmoidoscopy screening: comparison with an immunochemical test for occult blood (FlexSure OBT). Gut 53, 1329–1333 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Moran, A., Radley, S., Neoptolemos, J., Jones, A. F. & Asquith, P. Detection of colorectal cancer by faecal α1-antitrypsin. Ann. Clin. Biochem. 30, 28–33 (1993).
  Article PubMed Google Scholar
• Nakayama, T., Yasuoka, H., Kishino, T., Ohguchi, H. & Takada M. ELISA for occult faecal albumin. Lancet I, 1368–1369 (1987).
  Article Google Scholar
• Miyoshi, H., Ohshiba, S., Asada, S., Hirata, I. & Uchida K. Immunological determination of fecal hemoglobin and transferring levels: a comparison with other fecal occult blood tests. Am. J. Gastroenterol. 87, 67–73 (1992).
  CAS PubMed Google Scholar
• Dubrow, R., Kinm, C. S. & Eldred, A. K. Fecal lysozyme: an unreliable marker for colorectal cancer. Am. J. Gastroenterol. 87, 617–621 (1992).
  CAS PubMed Google Scholar
• Ahlquist, D. A. & Shuber, A. P. Stool screening for colorectal cancer: evolution from occult blood to molecular markers. Clin. Chim. Acta 315, 157–168 (2002).
  Article CAS PubMed Google Scholar
• Bader, G. & Papanicolaou, G. The application of cytology in the diagnosis of cancer of the rectum, sigmoid, and descending colon. Cancer 5, 307–314 (1952).
  Article CAS PubMed Google Scholar
• Lipkin, M., Bell, B. & Sherlock, P. Cell proliferation kinetics in the gastrointestinal tract of man. I. Cell renewal in colon and rectum. J. Clin. Invest. 42, 767–776 (1963).
  Article CAS PubMed PubMed Central Google Scholar
• Ahlquist, D. A., Harrington, J. J., Burgart, L. J. & Roche, P. C. Morphometric analysis of the 'mucocellular layer' overlying colorectal cancer and normal mucosa: relevance to exfoliation and stool screening. Hum. Pathol. 31, 51–57 (2000).
  Article CAS PubMed Google Scholar
• Loktionov, A. et al. Quantitation of DNA from exfoliated colonocytes isolated from human stool surface as a novel noninvasive screening test for colorectal cancer. Clin. Cancer Res. 4, 337–342 (1998).
  CAS PubMed Google Scholar
• Bandaletova, T., Bailey, N., Bingham, S. A. & Loktionov, A. Isolation of exfoliated colonocytes from human stool as a new technique for colonic cytology. APMIS 110, 239–246 (2002).
  Article PubMed Google Scholar
• Davies, R. J. et al. Analysis of minichromosome maintenance proteins as a novel method for detection of colorectal cancer in stool. Lancet 359, 1917–1919 (2002). In this paper, we demonstrated that markers of exfoliated cancer cells can accurately be detected in stool.
  Article CAS PubMed Google Scholar
• Moldenhauer, G., Momburg, F., Moller, P., Schwartz, R. & Hammerling, G. J. Epithelium-specific surface glycoprotein of Mr 34,000 is a widely distributed human carcinoma marker. Br. J. Cancer 56, 714–721 (1987).
  Article CAS PubMed PubMed Central Google Scholar
• Gonzalez, M. A., Tachibana, K. E., Laskey, R. A. & Coleman, N. Control of DNA replication and its potential clinical exploitation. Nature Rev. Cancer 5, 135–141 (2005).
  Article CAS Google Scholar
• Ishibashi, K., Hirose, K., Kato, H., Ogawa, K. & Haga, S. Determining the telomerase activity of exfoliated cells in intestinal lavage solution to detect colorectal carcinoma. Anticancer Res. 19, 2831–2836 (1999).
  CAS PubMed Google Scholar
• Luo, C., Zhao, D. & Qu, J. Telomerase activity in stool of patients with colorectal cancer. Zhonghua Wai Ke Za Zhi 39, 580–582 (2001).
  CAS PubMed Google Scholar
• Yokoyama, S. et al. The potential role of fecal carbonic anhydrase II in screening for colorectal cancer. Am. Surg. 63, 243–246 (1997).
  CAS PubMed Google Scholar
• Hardt, P. D. et al. Faecal tumour M2 pyruvate kinase: a new, sensitive screening tool for colorectal cancer. Br. J. Cancer 91, 980–984 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Mizuno, M. et al. Testing of multiple samples increases the sensitivity of stool decay-accelerating factor test for detection of colorectal cancer. Am. J. Gastroenterol. 98, 2550–2555 (2003).
  Article PubMed Google Scholar
• Kim, Y. et al. Gastrointestinal tract cancer screening using fecal carcinoembryonic antigen. Ann. Clin. Lab. Sci. 33, 32–38 (2003).
  PubMed Google Scholar
• Machiels, B. et al. New protocol for DNA extraction of stool. Biotechniques 28, 286–290 (2000).
  Article CAS PubMed Google Scholar
• Deuter, R., Pietsch, S., Hertel, S. & Muller, O. A method for preparation of fecal DNA suitable for PCR. Nucleic Acids Res. 23, 3800–3801 (1995).
  Article CAS PubMed PubMed Central Google Scholar
• Andreyev, H. J., Norman, A. R., Cunningham, D., Oates, J. R. & Clarke, P. A. Kirsten ras mutations in patients with colorectal cancer: the multicenter 'RASCAL' study. J. Natl Cancer Inst. 90, 675–684 (1998).
  Article CAS PubMed Google Scholar
• Sidransky, D. et al. Identification of ras oncogene mutations in the stool of patients with curable colorectal tumors. Science 256, 102–105 (1992). The first study to demonstrate that mutations can be detected in the stool of patients with CRC.
  Article CAS PubMed Google Scholar
• Frattini, M., Balestra, D., Pilotti, S., Bertario, L., Pierotti, M. A. Tumor location and detection of k-ras mutations in stool from colorectal cancer patients. J. Natl Cancer Inst. 95, 72–73 (2003).
  Article CAS PubMed Google Scholar
• Eguchi, S., Kohara, N., Komuta, K. & Kanematsu T. Mutations of the p53 gene in the stool of patients with resectable colorectal cancer. Cancer 77 (Suppl. 8), 1707–1710 (1996).
  Article CAS PubMed Google Scholar
• Lu, X., Xu, T., Qian, J., Wen, X. & Wu, D. Detecting K-ras and p53 gene mutation from stool and pancreatic juice for diagnosis of early pancreatic cancer. Chin. Med. J. 115, 1632–1636 (2002).
  CAS PubMed Google Scholar
• Powell, S. M. et al. APC mutations occur early during colorectal tumorigenesis. Nature 359, 235–237 (1992).
  Article CAS PubMed Google Scholar
• Fearnhead, N. S., Britton, M. P. & Bodmer, W. F. The ABC of APC. Hum. Mol. Genet. 10, 721–733 (2001).
  Article CAS PubMed Google Scholar
• Traverso, G. et al. Detection of APC mutations in fecal DNA from patients with colorectal tumors. N. Engl. J. Med. 346, 311–320 (2002).
  Article CAS PubMed Google Scholar
• Boland, C. R. Molecular genetics of hereditary nonpolyposis colorectal cancer. Ann. NY Acad. Sci. 910, 50–59 (2000).
  Article CAS PubMed Google Scholar
• Issa, J. P. CpG island methylator phenotype in cancer. Nature Rev. Cancer 4, 988–993 (2004).
  Article CAS Google Scholar
• Traverso, G. et al. Detection of proximal colorectal cancers through analysis of faecal DNA. Lancet 359, 403–404 (2002). Demonstrated that proximal CRCs can be detected using stool DNA analysis.
  Article CAS PubMed Google Scholar
• Bedi, A, et al. Inhibition of apoptosis during delopment of colorectal cancer. Cancer Res. 55, 1811–1816 (1995).
  CAS PubMed Google Scholar
• Boynton, K. A., Summerhayes, I. C., Ahlquist, D. A. & Shuber, A. P. DNA integrity as a potential marker for stool-based detection of colorectal cancer. Clin. Chem. 49, 1058–1065 (2003).
  Article CAS PubMed Google Scholar
• Ahlquist, D. A. et al. Novel use of hypermethylated DNA markers in stool for detection of colorectal cancer: a feasibility study. Gastroenterology 122, A40 (2002).
  Google Scholar
• Suzuki, H. et al. A genomic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancer. Nature Genet. 31, 141–149 (2002).
  Article CAS PubMed Google Scholar
• Muller, H. M. et al. Methylation changes in faecal DNA: a marker for colorectal cancer screening? Lancet 363, 1283–1285 (2004).
  Article PubMed CAS Google Scholar
• Brand, R. E., Ross, M. E. & Shuber, A. P. Reproducibility of a multitarget stool-based DNA assay for colorectal cancer detection. Am. J. Gastroenterol. 99, 1338–1341 (2004).
  Article CAS PubMed Google Scholar
• Imperiale, T. F. et al. Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population. N. Engl. J. Med. 351, 2704–2714 (2004). A detailed assessment of the performance of stool DNA testing in 2,507 average-risk asymptomatic individuals.
  Article CAS PubMed Google Scholar
• Schoen, R. E. Interrupting the adenoma-carcinoma sequence: screening for adenomas and cancer, now and in the future. Semin. Gastrointest. Dis. 11, 219–228 (2000).
  CAS PubMed Google Scholar
• Steele, R. J. C. et al. A demonstration pilot trial for colorectal cancer screening in the United Kingdom: a new concept in the introduction of healthcare strategies. J. Med. Screen. 8, 197–203 (2001).
  Article CAS PubMed Google Scholar
• Dukes, C. E. The classification of cancer of the rectum. J. Pathol. Bacteriol. 35, 323–332 (1932).
  Article Google Scholar
• Whittaker, M. & Goligher, J. C. The prognosis after surgical treatment for carcinoma of the rectum. Br. J. Surg. 63, 384–388 (1976).
  Article CAS PubMed Google Scholar
• Lieberman, D. A. & Weiss, D. G. One-time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon. N. Engl. J. Med. 345, 555–560 (2001).
  Article CAS PubMed Google Scholar
• UK Flexible Sigmoidoscopy Screening Trial Investigators. Single flexible sigmoidoscopy screening to prevent colorectal cancer: baseline findings of a UK multicentre trial. Lancet 359, 1291–1299 (2002).
• Segnan, N. et al. Baseline findings of the Italian multicenter randomised controlled trial of 'once-only flexible sigmoidoscopy'—SCORE. J. Natl Cancer Inst. 94, 1763–1772 (2002).
  Article PubMed Google Scholar
• Citarda, F. et al. Efficacy in standard clinical practice of colonoscopic polypectomy in reducing colorectal cancer incidence. Gut 48, 812–815 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Winawer, S. J. et al. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N. Engl. J. Med. 329, 1977–1981 (1993).
  Article CAS PubMed Google Scholar
• Johnson, C. D. et al. Prospective blinded evaluation of computed tomographic colonography for screen detection of colorectal polyps. Gastroenterology 125, 311–319 (2003).
  Article PubMed Google Scholar
• Kamar, M. et al. Actual colonic perforation in virtual colonoscopy: report of a case. Dis. Colon Rectum 47, 1242–1246 (2004).
  Article PubMed Google Scholar
• Coady-Fariborzian, L., Angel, L. P. & Procaccino, J. A. Perforated colon secondary to virtual colonoscopy: report of a case. Dis. Colon Rectum 47, 1247–1249 (2004).
  Article PubMed Google Scholar
• Fidler, J. L. et al. Detection of flat lesions in the colon with CT colonography. Abdom. Imaging 27, 292–300 (2002).
  Article CAS PubMed Google Scholar
• Tagore, K. S. et al. Sensitivity and specificity of a stool DNA multitarget assay panel for the detection of advanced colorectal neoplasia. Clin. Colorectal Cancer 3, 47–53 (2003).
  Article CAS PubMed Google Scholar
• Ahlquist, D. A. et al. Colorectal cancer screening by detection of altered human DNA in stool: feasibility of a multitarget assay panel. Gastroenterology 119, 1219–1227 (2000). The first study to report the use of a multitarget DNA assay for molecular stool screening.
  Article CAS PubMed Google Scholar
• Rengucci, C. et al. Multiple detection of genetic alterations in tumors and stool. Clin. Cancer Res. 7, 590–593 (2001).
  CAS PubMed Google Scholar
• Dong, S. M. et al. Detecting colorectal cancer in stool with the use of multiple genetic targets. J. Natl Cancer Inst. 93, 858–865 (2001).
  Article CAS PubMed Google Scholar
• Koshiji, M., Yonekura, Y., Saito, T. & Yoshioka, K. Microsatellite analysis of fecal DNA for colorectal cancer detection. J. Surg. Oncol. 80, 34–40 (2002).
  Article CAS PubMed Google Scholar